2,308 reports of this reaction
11.1% of all OXYMORPHONE HYDROCHLORIDE reports
#4 most reported adverse reaction
OVERDOSE is the #4 most commonly reported adverse reaction for OXYMORPHONE HYDROCHLORIDE, manufactured by Amneal Pharmaceuticals LLC. There are 2,308 FDA adverse event reports linking OXYMORPHONE HYDROCHLORIDE to OVERDOSE. This represents approximately 11.1% of all 20,768 adverse event reports for this drug.
Patients taking OXYMORPHONE HYDROCHLORIDE who experience overdose should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
OVERDOSE is a frequently reported adverse event for OXYMORPHONE HYDROCHLORIDE, accounting for a significant proportion of all reports.
In addition to overdose, the following adverse reactions have been reported for OXYMORPHONE HYDROCHLORIDE:
The following drugs have also been linked to overdose in FDA adverse event reports:
OVERDOSE has been reported as an adverse event in 2,308 FDA reports for OXYMORPHONE HYDROCHLORIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
OVERDOSE accounts for approximately 11.1% of all adverse event reports for OXYMORPHONE HYDROCHLORIDE, making it a notable side effect.
If you experience overdose while taking OXYMORPHONE HYDROCHLORIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.